FKH has sited itself in the hotbeds of innovation. We connect our clients to the skills and partners they need for success.
Overlooking the Charles River and situated at the juxtaposition of the historic Longfellow Bridge and the ultra-modern Leonard P. Zakim Bridge, Feintstein Kean Healthcare is at the center of life sciences research and clinical care. A stone’s throw from the research facilities of Amgen, Novartis, Pfizer and Merck. Shouting distance to MIT, the Harvard genomics laboratories and Boston’s necklace of prestigious hospitals. Just blocks from dozens of VC-backed start-ups. Here, we have consulting expertise, policy knowledge, media savvy and connectivity to the world’s largest pharmaceutical companies, biopharmaceutical players, and academic superstars.
FKH is strategically located near the global headquarters of many of the world’s largest pharmaceutical companies. Here, our clients produce a pipeline of new therapeutic products to address chronic and intractable diseases. Our staff has devoted their careers to this industry, and they offer deep knowledge of how to engage with physicians, patients, and advocacy organizations who seek to improve clinical outcomes.
“Big Science” has been driven by many innovators at the National Institutes of Health, and FKH has been at their side and on their side. Nanotechnology. Genomics. Proteomics. Bioinformatics. We work with the experts who are driving these disciplines, helping them to change the culture of science, to link research with clinical care, to inform physicians, scientists, and policymakers, and to involve patient advocates. We help to build the ‘ecosystems’ that accelerate research and improve patient care. In addition, our deep connections in the health professional and patient advocacy communities help our clients build coalitions and engage stakeholders towards action.